Recent News

• 06.02.2026 - enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
• 06.02.2026 - enVVeno Medical to Participate in the Virtual Investor Closing Bell Series
• 05.12.2026 - enVVeno Medical Discusses FDA IDE Approval in Virtual Investor “What This Means” Segment
• 05.07.2026 - enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
• 04.29.2026 - enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
• 02.04.2026 - enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Recent Filings

• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.29.2026 - EX-99.1 EX-99.1
• 04.29.2026 - 8-K Current report
• 03.26.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 03.26.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 03.12.2026 - 144 Report of proposed sale of securities
• 02.20.2026 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership